Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

FDA’s Opioid Guidance: Industry Celebrates Multi-Tiered Labeling Cake

Related Content

Abuse Reduction Claim In Opioid Label Will Be Difficult To Attain

Jan 10 2013

Opioid REMS Requires Sponsors To Launch Prescriber Training CME Within 9 Months

Jul 10 2012

OxyContin Abuse-Deterrent Formulation Has Addicts Switching To Heroin

Jul 16 2012

Opioid Abuse-Deterrent Formulations Could Become Prerequisite To Approval

Dec 17 2012

Related Companies

Endo, Inc.

Grunenthal GmbH

Purdue Pharma L.P.

Zogenix, Inc.

Additional Topics

United States Regulation Safety Legislation Drug Approval Standards BioPharmaceutical

More from United States

More from North America

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window